Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
about
Neoplastic disease after liver transplantation: Focus on de novo neoplasmsSkin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repairSkin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatmentCyclophilin B expression is associated with in vitro radioresistance and clinical outcome after radiotherapy.More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) CohortUpdate on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Oxidative stress-induced DNA damage and repair in human peripheral blood mononuclear cells: protective role of hemoglobin.Risk of merkel cell carcinoma after solid organ transplantation.Downregulation of telomerase maintenance-related ACD expression in patients undergoing immunosuppresive therapy following kidney transplantationSirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.Cyclosporin-A associated malignancy.Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.Immunosuppression and hepatocellular carcinoma.Assays to determine DNA repair ability.Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.Liver Transplantation for HCC: A Review.The influence of mTOR inhibitors on immunity and the relationship to post-transplant malignancyPost-transplantation malignancies: here today, gone tomorrow?Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis.CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair.Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States.Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis.Cytomegalovirus-negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation.Cyclosporine A Inhibits the T-bet-Dependent Antitumor Response of CD8(+) T Cells.Solid tumors following kidney transplantation in children.Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network.The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
P2860
Q26798306-ACAF3A4B-B143-4273-8A5C-C2F8FADEF544Q26822549-8911AF3C-CCED-4CC3-B2F5-B00C86FCA304Q26851436-59C1AC09-4C1C-45ED-83EF-41DEE6E30832Q26852299-1AB22478-00C3-48A0-984D-D8DA054350E8Q30428813-7B3E3CD0-1143-4803-BB63-FEDB43AF594CQ30835452-333192E0-ADDE-440E-8A7C-0C71B48A4FE9Q33575450-756920A6-4108-4B3A-8693-6EA90C1B50BDQ33880261-F485456A-36FB-45C4-B2C1-B9169F9D0F9CQ34078707-D52F0665-BD5C-47C6-8F71-EBA2DFF15F75Q34848111-9B889AFA-2E9E-4F74-A334-C8102C16F829Q35029320-5D3E1A96-5B64-45FF-84EE-64D2441C1DDAQ35868949-521D1B10-7BE5-4D1F-99D0-1BBB5B4FBFE0Q36051817-0CFA053E-08EF-4843-B9EA-EB402D7F2088Q37247310-734D8CBB-4F17-4A38-ACB3-E1B31D48F8D7Q37393836-44E4F033-59B0-4A7D-8946-98DF3422EF59Q37867072-87333645-BE35-46EC-980E-DFE3AC5C19B9Q37894725-D13B58E8-E14A-4987-84EE-87D034CBC640Q37933157-DA61D0C3-CF36-476F-9C72-840F533F153CQ38078347-6E3F8FED-4AE0-4EC2-81F1-0F266CCB52CAQ38190674-12BCB6BB-A1BA-4F2F-B5AE-6229380D82FAQ38611709-ABBDDC4A-B0C4-45C5-B663-9C381556FCACQ38830835-421B6936-C71E-4793-8C19-AAEFC978D771Q39806223-F3E352E7-5B95-4951-B18D-D0828A8A49BAQ40012751-3D8C93DB-F536-4216-8687-2965EA82EFA1Q40257939-DC3C8170-05F7-417D-9808-34AAD80028DFQ46845821-7007BB3F-47D0-41CF-BCA4-E2B290365CE9Q50226200-046B0E4F-29C1-48BC-96A3-98A3C63B0E73Q53180942-4E239E67-BCAF-46C6-A018-54EE08999C79Q54687840-41DB47FA-5CBC-44A1-85D3-1766B83F0B48Q55266341-01CB329D-E171-4A01-A65C-C5126A80D340Q58756343-7DDF0036-83FE-4C72-A55D-86BF32C9B51A
P2860
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@ast
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@en
type
label
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@ast
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@en
prefLabel
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@ast
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@en
P2093
P356
P1476
Effect of cyclosporin A on DNA ...... kidney transplant recipients.
@en
P2093
Weinstein T
P356
10.1067/MLC.2001.111469
P577
2001-01-01T00:00:00Z